Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients.

British journal of cancer - 22 Nov 2011

Lundin K B, Henningson M, Hietala M, Ingvar C, Rose C, Jernström H

Abstract excerpt

BACKGROUND: The androgen receptor (AR) is frequently expressed in breast cancers. The AR genotype may affect disease-free survival and response to endocrine therapy. METHODS: In all, 634 women undergoing breast cancer surgery between 2002 and 2008 were followed until 30 June 2010. Six haplotype-tagging single-nucleotide polymorphisms in the AR, and the resulting AR diplotypes, were examined in relation to breast...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Aromatase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Breast Neoplasms

Share to Disease-Free Survival

Share to Neoplasms, Hormone-Dependent

Share to Receptors, Androgen

Share to Tamoxifen

Source

Open in PubMed Open full text

Identifiers

PMID: 22033271
DOI: 10.1038/bjc.2011.441
PMCID: PMC3242599

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients.PMID 22033271Read ↗

The implications of genetic variation for the pharmacokinetics and pharmacodynamics of aromatase inhibitors.Semantic proximity Read ↗

Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early-Stage Breast Cancer.Semantic proximity Read ↗

Androgen receptor htSNPs in relation to androgen levels and OC use in young women from high-risk breast cancer families.Semantic proximity Read ↗

Androgen receptor-mediated pharmacogenomic expression quantitative trait loci: implications for breast cancer response to AR-targeting therapy.Semantic proximity Read ↗

Research on aromatase gene (CYP19A1) polymorphisms as a predictor of endocrine therapy effectiveness in breast cancer.Semantic proximity Read ↗

Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic eventsSemantic proximity Read ↗

Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators.Semantic proximity Read ↗

Pharmacogenomics of third-generation aromatase inhibitors.Semantic proximity Read ↗

Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients.Semantic proximity Read ↗

Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.Semantic proximity Read ↗

The impact of CYP19A1 variants and haplotypes on breast cancer risk, clinicopathological features and prognosis.Semantic proximity Read ↗

ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.